Innogen Co., Ltd. (344860) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Innogen Co., Ltd. (344860:KRX), powered by AI.

Current Price
₩1,583
P/E Ratio
66.2
Market Cap
19.0B
Sector
Unknown
What is the Innogen Co., Ltd. stock price forecast?

Innogen Co., Ltd. is currently trading at ₩1,583. View real-time AI analysis on Alpha Lenz.

What is Innogen Co., Ltd. insider trading activity?

View the latest insider trading data for Innogen Co., Ltd. on Alpha Lenz.

What is Innogen Co., Ltd.'s P/E ratio?

Innogen Co., Ltd.'s P/E ratio is 66.2.

Innogen Co., Ltd.

KRX · 344860
₩1,583+133(+9.17%)Market closedKRX regular session 09:00–15:30 KST
Ask about Innogen Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Innogen Co., Ltd. trades at a P/E of 66.2 (premium valuation) with modest ROE of 1.9%.

Ask for details

Company Overview

CEO이광훈
SectorUnknown
IndustryUnknown
0

Company Statistics

FY 2025

Profile

₩19,043,490,000Market Cap
₩8,213,447,240Revenue
12.03MShares Out
0Employees

Margins

75.72%Gross
6.97%EBITDA
0.05%Operating
3.12%Pre-Tax
3.50%Net

Valuation

66.15P/E
1.35P/B
2.32EV/Sales
30.68EV/EBITDA
46.29P/FCF

Growth (CAGR)

-3.50%Rev 3Yr
2.72%Rev 5Yr
-85.55%Op Inc 3Yr
-66.87%Op Inc 5Yr
-40.10%Net Inc 3Yr
-18.28%Net Inc 5Yr

Returns

1.77%ROA
1.88%ROE
1.60%ROIC

Financial Health

₩1,584,562,520Cash & Cash Equivalents
₩-645,740,960Net Debt
6.66%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Innogen Co., Ltd. (ticker: 344860) is a company listed on KRX in the Unknown sector (Unknown). Market cap is $19.0B.

The current price is ₩1,583 with a P/E ratio of 66.15x and P/B of 1.35x.

ROE is 1.88% and operating margin is 0.05%. Annual revenue is $8.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Innogen Co., Ltd. (344860) Stock Forecast 2026 ₩1,583 — Price, Financials & Analyst Targets | Alpha Lenz